Hinge Health, Inc.
Financial highlights
| Metric | FY December 31, 2025 | FY December 31, 2024 | FY December 31, 2023 |
|---|---|---|---|
| Revenue | $587.9M | $390.4M | $292.7M |
| Gross profit | $468.2M | $299.9M | $194.2M |
| Operating income | -$546.4M | -$31.9M | -$130.5M |
| Operating expenses | $1.0B | $331.8M | $324.7M |
| Cost of revenue | $119.6M | $90.5M | $98.6M |
| Cash from operations | $171.4M | $49.0M | -$63.9M |
| Capital expenditure | $708,000 | $1.0M | $2.0M |
| Free cash flow | $170.7M | $48.0M | -$65.9M |
| Share repurchases | $65.0M | $0 | $0 |
| Impairments | $0 | $0 | $0 |
| Total assets | $744.8M | $673.3M | — |
| Total liabilities | $366.2M | $256.6M | — |
Shares outstanding 77.4M · Free float 76.7%
Annual filing data through FY ended December 31, 2025; float as of June 27, 2026.